Trial Profile
Randomized Comparison of Cyclophosphamide Versus Fludarabine in Addition to Anti-thymocyte Globulin for the Conditioning Therapy in Allogeneic Hematopoietic Cell Transplantation for Bone Marrow Failure Syndrome.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Cyclophosphamide (Primary) ; Fludarabine (Primary) ; Antithymocyte globulin; Ciclosporin; Methotrexate
- Indications Aplastic anaemia; Graft-versus-host disease; Myelodysplastic syndromes; Paroxysmal nocturnal haemoglobinuria
- Focus Adverse reactions; Therapeutic Use
- Acronyms CyATG-FluATG
- 21 Jun 2010 New trial record